Massachusetts Financial Services CO Gritstone Bio, Inc. Transaction History

Massachusetts Financial Services CO

  • $320 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$8.76 - $13.71 $670,288 - $1.05 Million
-76,517 Closed
0 $0
Q3 2021

Nov 10, 2021
SELL
$6.41 - $13.54 $6,429 - $13,580
-1,003 Reduced 1.29%
76,517 $826,000
Q2 2021

Aug 13, 2021
BUY
$8.13 - $10.2 $5,382 - $6,752
662 Added 0.86%
77,520 $708,000
Q1 2021

May 13, 2021
BUY
$4.07 - $27.11 $312,812 - $2.08 Million
76,858 New
76,858 $725,000

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email